A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma
Clinical trial NCT07691762 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07691762
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2031-04-01
- Enrollment
- 690
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.